The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

May. 16, 2019
Applicant:

Obalon Therapeutics, Inc., Carlsbad, CA (US);

Inventors:

Mark C. Brister, Encinitas, CA (US);

Nelson Quintana, San Diego, CA (US);

Kaushik A. Patel, Poway, CA (US);

Neil R. Drake, San Diego, CA (US);

Antonio C. Llevares, Chula Vista, CA (US);

Dubravka Markovic, Carlsbad, CA (US);

Andrew P. Rasdal, San Diego, CA (US);

Amy D. L. VandenBerg, San Diego, CA (US);

Assignee:

RESHAPE LIFESCIENCES INC., San Clemente, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 17/12 (2006.01); A61F 5/00 (2006.01); A61M 31/00 (2006.01); A61B 90/00 (2016.01); A61M 25/10 (2013.01); A61L 31/08 (2006.01); A61L 31/10 (2006.01);
U.S. Cl.
CPC ...
A61F 5/003 (2013.01); A61B 90/39 (2016.02); A61F 5/0036 (2013.01); A61F 5/0073 (2013.01); A61F 5/0083 (2013.01); A61L 31/088 (2013.01); A61L 31/10 (2013.01); A61M 25/1029 (2013.01); A61M 25/10185 (2013.11); A61M 31/002 (2013.01); A61B 17/1204 (2013.01); A61B 17/12099 (2013.01); A61B 2090/3966 (2016.02); A61L 2400/16 (2013.01); A61L 2420/02 (2013.01); A61L 2420/08 (2013.01); A61M 25/1027 (2013.01); A61M 2025/105 (2013.01); A61M 2025/1031 (2013.01); Y10T 156/1051 (2015.01);
Abstract

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.


Find Patent Forward Citations

Loading…